🇺🇸 GKOS — Glaukos Corporation

Salud Compra fuerte
← Volver

Precio actual

233,04 USD

Máx. histórico

242,48

5 días

Caída desde máximo

-3,89%

Rango 52 semanas

80,91 – 248,75

Variación hoy

-2,33%

Cierre anterior

238,61

Rango de hoy

230,00 – 240,76

Volumen hoy

10.706.919

Peor caída histórica

-69,57%

01/08/2019 → 20/03/2020

Recuperado en 299 días

Volatilidad anualizada ⓘ

54,27%

Información
Nombre completo
Glaukos Corporation
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Medical Devices
Empleados
1.094
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
242,46 USD (puede no estar actualizado)
Primera cotización
25/06/2015
Precio actualizado
hace 17 horas
Sobre la empresa

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. It offers iStent and iStent inject W micro-bypass stents designed to treat mild-to-moderate open-angle glaucoma through the restoration of the natural physiologic outflow pathways for aqueous humor. The company also provides iStent infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. In addition, the company develops iLink, a device used for the treatment of keratoconus without the removal of the epithelium; ILution, a platform of cream-based drug formulation applied to the outer surface of the eyelid for drop less transdermal delivery of pharmaceutically active compounds for the treatment of anterior segment eye disorders; and retinal XR platform to treat age-related macular degeneration, diabetic macular edema, retinal vein occlusion, and other posterior segment retinal diseases. It sells its products to ambulatory surgery centers, hospitals, and physician private practices through a direct sales organization, direct sales subsidiaries, and distributors. The company was formerly known as Transdx, Inc. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
23/12/2015 24,64 26,36 24,25 25,91 +2,78% 8,56% 114.700
22/12/2015 24,25 25,30 24,15 25,21 +3,19% 4,74% 86.900
21/12/2015 24,32 25,46 24,32 24,43 +0,29% 4,69% 127.000
18/12/2015 24,65 24,95 24,08 24,36 -1,85% 3,53% 163.300
17/12/2015 24,80 24,97 24,46 24,82 +0,16% 2,06% 86.300
16/12/2015 23,49 24,80 23,32 24,78 +7,04% 6,30% 113.600
15/12/2015 22,20 23,38 22,20 23,15 +5,37% 5,32% 89.400
14/12/2015 22,18 22,38 21,82 21,97 -1,08% 2,52% 67.100
11/12/2015 23,43 23,65 22,05 22,21 -6,44% 6,83% 71.600
10/12/2015 23,95 24,23 23,48 23,74 -0,34% 3,13% 88.100
09/12/2015 23,59 23,96 23,35 23,82 +1,23% 2,59% 73.000
08/12/2015 23,45 23,68 23,17 23,53 +0,34% 2,17% 71.900
07/12/2015 23,59 23,89 23,12 23,45 -0,93% 3,26% 62.600
04/12/2015 23,23 23,76 23,03 23,67 +1,46% 3,14% 71.900
03/12/2015 24,53 24,92 23,20 23,33 -5,24% 7,01% 121.800
02/12/2015 24,72 25,22 24,35 24,62 -0,77% 3,52% 96.900
01/12/2015 25,88 25,88 24,55 24,81 -4,21% 5,14% 134.000
30/11/2015 26,27 26,27 25,48 25,90 -1,37% 3,01% 130.500
27/11/2015 26,93 26,93 26,20 26,26 -2,27% 2,71% 21.900
25/11/2015 26,41 26,97 26,26 26,87 +2,01% 2,69% 98.600
24/11/2015 25,12 26,52 25,12 26,34 +3,99% 5,57% 84.000
23/11/2015 26,00 26,51 25,09 25,33 -2,24% 5,46% 111.200
20/11/2015 25,95 27,64 25,80 25,91 +1,17% 7,09% 177.200
19/11/2015 25,57 25,90 25,31 25,61 -0,04% 2,30% 77.800
18/11/2015 24,54 25,68 24,54 25,62 +4,40% 4,65% 123.700
17/11/2015 24,46 24,73 23,80 24,54 +1,11% 3,80% 97.600
16/11/2015 24,09 24,67 23,86 24,27 +0,66% 3,36% 153.000
13/11/2015 22,18 24,30 22,18 24,11 +9,64% 9,56% 294.500
12/11/2015 21,99 22,18 21,52 21,99 +0,00% 3,00% 289.300
11/11/2015 22,84 22,84 20,55 21,99 +17,22% 10,05% 867.200